Search Tag: antibodies

ICU Management

Xencor-appoints-barbara-j-klencke-m-d-to-board-of-directors

2023 19 Sep

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of biopharmaceutical product development experience, and she most recently served...Read more

ICU Management

First-ever-possible-treatments-for-mers

2015 03 Jul

As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, University of Maryland School of Medicine scientists have announced the discovery of two therapeutics that show potential in preventing and treating the disease. The treatments are the first to succeed in protecting and treating animal models of the MERS virus;...Read more